FATE Stock-Based Compensation
Fate Therapeutics Inc · Stock-Based Compensation
FATE Stock-Based Compensation
Latest reported$3.52Mperiod ending
FATE Quarterly Stock-Based Comp ($42.00K → $3.52M)
Quarterly stock-based compensation
High-resolution chart · PNG
FATE stock-based compensation history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 3,518,000 | |
| 3,929,000 | |
| 5,528,000 | |
| 4,861,000 | |
| 7,154,000 | |
| 7,381,000 | |
| 9,120,000 | |
| 11,765,000 | |
| 9,630,000 | |
| 10,981,000 | |
| 0 | |
| 10,104,000 | |
| 0 | |
| 10,983,000 | |
| 0 | |
| 19,468,000 | |
| 20,542,000 | |
| 19,331,000 | |
| 14,594,000 | |
| 13,540,000 | |
| 13,254,000 | |
| 12,976,000 | |
| 8,761,000 | |
| 7,843,000 | |
| 7,236,000 | |
| 6,913,000 | |
| 4,583,000 | |
| 4,573,000 | |
| 4,386,000 | |
| 3,868,000 | |
| 1,784,000 | |
| 1,642,000 | |
| 1,485,000 | |
| 1,382,000 | |
| 895,000 | |
| 871,000 | |
| 973,000 | |
| 867,000 | |
| 819,000 | |
| 782,000 | |
| 786,000 | |
| 797,000 | |
| 480,000 | |
| 574,000 | |
| 738,000 | |
| 608,000 | |
| 612,000 | |
| 527,000 | |
| 424,000 | |
| 871,000 | |
| 385,000 | |
| 982,000 | |
| 112,000 | |
| 75,000 | |
| 49,000 | |
| 42,000 |